Biolase (BIOL) Reports Q3 Loss of $0.09/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
BIOLASE Reports 2015 Third Quarter Results
November 4, 2015 4:05 PM ESTIRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for the third quarter and nine months ended September 30, 2015.
Selected highlights of the 2015 third quarter include:
Worldwide revenue of $11.2 million was down $1.5 million, or 12% year over year, largely attributable to $0.7 million lower imaging revenue, and $0.6 million lower service revenue (e.g. training and service agreements) related to a favorable change in accounting estimate made in Q3 2014 to recognize deferred training revenue over a shorter time... More